Lecanemab (Leqembi) & donanemab (Kisunla) are antiamyloid medicines approved for people with mild dementia due to Alzheimer's disease & mild cognitive impairment due to AD. Lecanemab is given as an IV infusion every 2 weeks. Donanemab is given as an IV infusion every 4 weeks.
Neither cures.
Neither cures.
February 25, 2025 at 2:35 AM
Lecanemab (Leqembi) & donanemab (Kisunla) are antiamyloid medicines approved for people with mild dementia due to Alzheimer's disease & mild cognitive impairment due to AD. Lecanemab is given as an IV infusion every 2 weeks. Donanemab is given as an IV infusion every 4 weeks.
Neither cures.
Neither cures.
Real answer: Trump receives Lecanemab (Leqembi) or Donanemab (Kisunla) via IV infusion in an effort to slow his cognitive loss due to his dementia.
Q: Can you explain what's going on with the bandages on Trump's hand?
LEAVITT: We've given you an explanation. The president is literally constantly shaking hands.
LEAVITT: We've given you an explanation. The president is literally constantly shaking hands.
December 11, 2025 at 9:48 PM
Real answer: Trump receives Lecanemab (Leqembi) or Donanemab (Kisunla) via IV infusion in an effort to slow his cognitive loss due to his dementia.
He is getting infusions of Leqembi (lecanemab) and/or Donanemab to treat Alzheimer's, I'm convinced of it.
Trump's *left* hand -- not the one that is usually disfigured -- now has a large bruise and is discolored
These pictures are from today in Davos and are via Chip Somodevilla (Getty) and Fabrice Coffrini (AFP)
These pictures are from today in Davos and are via Chip Somodevilla (Getty) and Fabrice Coffrini (AFP)
January 22, 2026 at 7:21 PM
He is getting infusions of Leqembi (lecanemab) and/or Donanemab to treat Alzheimer's, I'm convinced of it.
Or the IV treatments for dementia/Parkinson’s (lecanemab (Leqembi) and donanemab (Kisunla)) that require infusion every 2 weeks…
July 15, 2025 at 10:45 PM
Or the IV treatments for dementia/Parkinson’s (lecanemab (Leqembi) and donanemab (Kisunla)) that require infusion every 2 weeks…
Donanemab is administered intravenously every four weeks and requires regular MRIs.
![Ben Terris
@bterris
X.com
"[My father] had one problem," Trump said. "
He started getting, what do they call it?" He pointed to his forehead and looked to his press secretary for the word that escaped him.
"Alzheimer's," Leavitt said.
"Like an Alzheimer's thing," Trump said. "Well, I don't have it."](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:drfb2pdjlnsqkfgsoellcahm/bafkreiddfjrkrizv6r5szmevc7gl3bgwmcoub2i7ondb7cpnnqslhsjtvi)
January 26, 2026 at 3:45 PM
Donanemab is administered intravenously every four weeks and requires regular MRIs.
lecanemab or donanemab
January 22, 2026 at 4:35 PM
lecanemab or donanemab
JUST IN: The FDA has approved Eli Lilly's treatment for early Alzheimer's disease.
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease | CNN
The US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease.
cnn.it
July 2, 2024 at 5:59 PM
JUST IN: The FDA has approved Eli Lilly's treatment for early Alzheimer's disease.
Eli Lilly launches Alzheimer's drug Donanemab in India reut.rs/4no9btg
Eli Lilly launches Alzheimer's drug Donanemab in India
U.S.-based drugmaker Eli Lilly on Wednesday launched its Alzheimer's drug Lormalzi, also known as Donanemab, in India.
reut.rs
May 13, 2026 at 3:15 PM
Eli Lilly launches Alzheimer's drug Donanemab in India reut.rs/4no9btg
Breaking News: A panel of experts recommended that the FDA approve the newest experimental drug to treat Alzheimer’s disease, donanemab, made by Eli Lilly.
Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug
The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.
www.nytimes.com
June 10, 2024 at 9:16 PM
Breaking News: A panel of experts recommended that the FDA approve the newest experimental drug to treat Alzheimer’s disease, donanemab, made by Eli Lilly.
Intravenous (IV) drug treatments (via hand) for early Alzheimer's disease, such as lecanemab (brand name Leqembi®) and donanemab (brand name Kisunla™), utilize MRI scans (umm, has he had those?) extensively for both patient screening and safety monitoring.
December 10, 2025 at 4:13 PM
Intravenous (IV) drug treatments (via hand) for early Alzheimer's disease, such as lecanemab (brand name Leqembi®) and donanemab (brand name Kisunla™), utilize MRI scans (umm, has he had those?) extensively for both patient screening and safety monitoring.
In case you know someone taking MRIs 6 months apart.
Kisunla (generic name: donanemab-azbt) is a monoclonal antibody medication developed by Eli Lilly and Company for the treatment of early-stage symptomatic Alzheimer's disease, including mild cognitive impairment or mild dementia.
Kisunla (generic name: donanemab-azbt) is a monoclonal antibody medication developed by Eli Lilly and Company for the treatment of early-stage symptomatic Alzheimer's disease, including mild cognitive impairment or mild dementia.
November 18, 2025 at 4:05 AM
In case you know someone taking MRIs 6 months apart.
Kisunla (generic name: donanemab-azbt) is a monoclonal antibody medication developed by Eli Lilly and Company for the treatment of early-stage symptomatic Alzheimer's disease, including mild cognitive impairment or mild dementia.
Kisunla (generic name: donanemab-azbt) is a monoclonal antibody medication developed by Eli Lilly and Company for the treatment of early-stage symptomatic Alzheimer's disease, including mild cognitive impairment or mild dementia.
It seems all too obvious that Trump is on Donanemab, given monthy via IV. That would explain the hand bruising. It would also explain the MRI, since it can cause bleeding in the brain that can be seen on MRI scans.
December 2, 2025 at 9:57 PM
It seems all too obvious that Trump is on Donanemab, given monthy via IV. That would explain the hand bruising. It would also explain the MRI, since it can cause bleeding in the brain that can be seen on MRI scans.
Ketamine and Donanemab. 💯
February 26, 2025 at 7:01 AM
Ketamine and Donanemab. 💯
Scientists are nearing the development of pills to prevent or reduce Alzheimer's effects. In 2024, lecanemab and donanemab, shown to slow dementia decline by 30%, were approved by several regulators, with 127 more drugs in trials. https://buff.ly/3C9qL1b
#ShareGoodNewsToo
#ShareGoodNewsToo
Breakthrough drugs herald ‘new era’ in battle against dementia, experts predict
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally
buff.ly
January 22, 2025 at 2:50 PM
Scientists are nearing the development of pills to prevent or reduce Alzheimer's effects. In 2024, lecanemab and donanemab, shown to slow dementia decline by 30%, were approved by several regulators, with 127 more drugs in trials. https://buff.ly/3C9qL1b
#ShareGoodNewsToo
#ShareGoodNewsToo
When the truth comes out about why Trump is repeatedly going for medical checkups, it will seem absolutely insane.
Protip: This visit schedule, the bruises on his hands, the repeated cognitive tests, repeated MRIs are all consistent with Lecanemab, or Donanemab treatment.
Protip: This visit schedule, the bruises on his hands, the repeated cognitive tests, repeated MRIs are all consistent with Lecanemab, or Donanemab treatment.
Trump is set to visit Walter Reed on Tuesday for his 3rd checkup in 13 months.
Asked about the visit, White House officials touted reports Trump is in "exceptional" health.
Outside physicians said there are legitimate health questions about the nearly 80-year-old president.
Asked about the visit, White House officials touted reports Trump is in "exceptional" health.
Outside physicians said there are legitimate health questions about the nearly 80-year-old president.
Trump faces health questions ahead of another Walter Reed trip
The president trumpets claims that he is in excellent health, but independent physicians say the White House hasn't answered key questions ahead of his third visit in 13 months.
wapo.st
May 25, 2026 at 3:42 PM
When the truth comes out about why Trump is repeatedly going for medical checkups, it will seem absolutely insane.
Protip: This visit schedule, the bruises on his hands, the repeated cognitive tests, repeated MRIs are all consistent with Lecanemab, or Donanemab treatment.
Protip: This visit schedule, the bruises on his hands, the repeated cognitive tests, repeated MRIs are all consistent with Lecanemab, or Donanemab treatment.
#AskDrMia is sharing tips you may not know when considering infusion medications like #Lecanemab #Donanemab #Leqembi #Kisnula for #dementia. Stream the whole episode wherever you stream your #Podcasts.
youtube.com/shorts/j4D-I...
youtube.com/shorts/j4D-I...
Travel Warning for Patients on #Lecanemab #Donanemab #Leqembi #Kisunla #dementia #alzheimer #memory
YouTube video by Ask Dr. Mia- Navigating Dementia Caregiving
youtube.com
September 24, 2026 at 11:40 AM
#AskDrMia is sharing tips you may not know when considering infusion medications like #Lecanemab #Donanemab #Leqembi #Kisnula for #dementia. Stream the whole episode wherever you stream your #Podcasts.
youtube.com/shorts/j4D-I...
youtube.com/shorts/j4D-I...
I’ve seen speculation that he’s on Kinsula, which would explain both the IV bruises as the two MRIs spaced exactly six months apart.
Donanemab - Wikipedia
en.wikipedia.org
November 30, 2025 at 11:43 PM
I’ve seen speculation that he’s on Kinsula, which would explain both the IV bruises as the two MRIs spaced exactly six months apart.
The TGA has approved a drug to treat Alzheimer's disease.
Clinical trials have shown Donanemab can help in the early stages of the disease
The pharmaceutical Co that makes the drug said an application for Donanemab to be listed on the PBS would be reviewed by the advisory committee in July
#auspol
Clinical trials have shown Donanemab can help in the early stages of the disease
The pharmaceutical Co that makes the drug said an application for Donanemab to be listed on the PBS would be reviewed by the advisory committee in July
#auspol
First drug to target cause of Alzheimer's approved for use in Australia
The TGA has approved a drug found to slow the cognitive decline associated with Alzheimer's disease but it will only be available for a select few who can afford it privately.
www.abc.net.au
May 22, 2025 at 2:11 AM
The TGA has approved a drug to treat Alzheimer's disease.
Clinical trials have shown Donanemab can help in the early stages of the disease
The pharmaceutical Co that makes the drug said an application for Donanemab to be listed on the PBS would be reviewed by the advisory committee in July
#auspol
Clinical trials have shown Donanemab can help in the early stages of the disease
The pharmaceutical Co that makes the drug said an application for Donanemab to be listed on the PBS would be reviewed by the advisory committee in July
#auspol
He's on his monthly donanemab infusion, though, and out of it today. Wait 48 hours.
January 27, 2026 at 2:32 AM
He's on his monthly donanemab infusion, though, and out of it today. Wait 48 hours.
🧪
#alzheimer
#amyloid
Amazing new paper from @sfackley.bsky.social that exposes the statistical alchemy Lilly applied to their donanemab data:
jamanetwork.com/journals/jam...
There is little to no correlation between amyoid removal and clinical outcomes with donanemab (or lecanemab).
#alzheimer
#amyloid
Amazing new paper from @sfackley.bsky.social that exposes the statistical alchemy Lilly applied to their donanemab data:
jamanetwork.com/journals/jam...
There is little to no correlation between amyoid removal and clinical outcomes with donanemab (or lecanemab).
Methodological Considerations for Quantile Aggregation in Alzheimer Disease Trials
This study evaluates the quantile-aggregation method using both simulated data and publicly available Alzheimer disease randomized trial data.
jamanetwork.com
May 18, 2026 at 3:46 PM
🧪
#alzheimer
#amyloid
Amazing new paper from @sfackley.bsky.social that exposes the statistical alchemy Lilly applied to their donanemab data:
jamanetwork.com/journals/jam...
There is little to no correlation between amyoid removal and clinical outcomes with donanemab (or lecanemab).
#alzheimer
#amyloid
Amazing new paper from @sfackley.bsky.social that exposes the statistical alchemy Lilly applied to their donanemab data:
jamanetwork.com/journals/jam...
There is little to no correlation between amyoid removal and clinical outcomes with donanemab (or lecanemab).
“Also you need to have a monthly IV drip of donanemab or lecanemab, but don’t worry your make up skills will hide the bruising”
November 4, 2025 at 7:15 PM
“Also you need to have a monthly IV drip of donanemab or lecanemab, but don’t worry your make up skills will hide the bruising”